EGFR and non-small cell lung carcinoma: In a study of 336 treatment-naïve EGFR-mutated NSCLC, authors also provided evidence for a low immunogenicity of EGFR-mutated NSCLC by analyzing the TCGA data and an independent validation cohort of patients [73].